About Us
Mission & History
Business Model
Donors
Governance
Stakeholders
Scientific Advisors
Team
Jobs
Why New Drugs Now?
Threat of TB
Outdated Treatment
TB-HIV
Drug-Resistant TB
The Poverty Cycle
Developing New Treatments
Portfolio
Critical Path to TB Regimens
Strategic Initiatives
Regulatory Engagement
Adoption & Availability
AAA Mandate
Working with Constituencies
Engaging Policymakers
Laying the Groundwork
NewsCenter
News from the TB Alliance
News About Us
Latest TB News
Publications
Multimedia
Resources
Events
Media Support
Contact Us
Prev
-
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
Prev
-
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
Search:
SEARCH
Media Support Section
click here
For additional information please email:
newsmedia@tballiance.org
View our Interactive Portfolio
> click here
TB TREATED LIKE OTHER RESPIRATORY DISEASES IN FUTURE
6/03/2010
Drug-resistant TB risk demands push for new drugs
5/18/2010
China fights growing problem of tuberculosis
1/06/2010
Hopes of new drugs, vaccines for tuberculosis
12/07/2009
New development in TB treatment
6/18/2009
J&J, nonprofit join to speed TB drug development
6/17/2009
click to view all items
Open Forum 4
8/18/2010
Medicines for Neglected Diseases Workshop
9/10/2010
2010 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
9/12/2010
IUATLD Annual Conference 2010
11/11/2010
click to view all items
2009 TB Alliance Annual Report
Accelerating the Pace
March 2010 Newsletter
Click to view the newsletter
TB Alliance 2008 Financial Statement
New TB Regimens: What Countries Want
The Value Proposition of Existing and New First-Line Regimens for Drug-Susceptible Tuberculosis
© Global Alliance for TB Drug Development, All Rights Reserved